Back to
Aberdeen Group plc
ABVX
Showing 8 of 9 quarters
Position history for
Aberdeen Group plc's holdings in Abivax SA
Yes. Aberdeen Group holds 522,025 shares of ABVX (Abivax), worth $69.6M, as of its Q2 2026 13F filing. It increased the position by 90,784 shares (+21.1%) from Q1 2026. Aberdeen Group has held ABVX since Q2 2024, across 9 quarterly 13F filings. ABVX is 0.1% of Aberdeen Group's reported 13F portfolio.
Current Value
$69.6M
Current Shares
522,025
Total Value Change
+$65.9M
Total Shares Change
+205,594
Quarter-by-Quarter History